Testing effectiveness (Phase 2)Study completedNCT03953235
What this trial is testing
A Personalized Cancer Vaccine Targeting Shared Neoantigens
Who this might be right for
Non-Small Cell Lung CancerColorectal CancerPancreatic Cancer+2 more
Gritstone bio, Inc. 39